Literature DB >> 28919109

Long-Term Measurements of Human Inflammatory Cytokines Reveal Complex Baseline Variations between Individuals.

Danlu Wu1, Trinh L Dinh1, Bruce P Bausk1, David R Walt2.   

Abstract

Comprehensive characterization of the healthy human proteome baseline is essential for personalized medicine. Baseline data are necessary to understand the variation between individuals, as well as longitudinal variation within individuals. Many important protein biomarkers, such as cytokines, exist at extremely low or undetectable levels in the healthy state. This paper describes results from a 14-week study of healthy human subjects using ultrasensitive single-molecule array (Simoa) assays to measure both intra and intersubject variation of 15 cytokines. The results show a wide variation in the ranges of some cytokines between individuals and demonstrate that individual baseline values will be essential for predicting disease presence and progression. Although all of the studied cytokines demonstrated high temporal stability (or low intrasubject variation) over the entire study period, there were two distinct groups of cytokines that demonstrated either high (IL-8, IFN-γ, IL-2, IL-6, and IL-1β) or low (IL-15, TNF-α, IL-12 p70, IL-17A, GM-CSF, IL-12 p40, IL-10, IL-7, IL-1α, and IL-5) subject-to-subject variation. This work demonstrates that ultrasensitive assays are essential for characterizing human cytokines in healthy subjects. The results show that some cytokines vary by more than two orders of magnitude between individuals, making it an imperative to obtain individual baseline measurements if they are to play a role in health and disease diagnosis.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28919109     DOI: 10.1016/j.ajpath.2017.08.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

Review 1.  Enabling Technologies for Personalized and Precision Medicine.

Authors:  Dean Ho; Stephen R Quake; Edward R B McCabe; Wee Joo Chng; Edward K Chow; Xianting Ding; Bruce D Gelb; Geoffrey S Ginsburg; Jason Hassenstab; Chih-Ming Ho; William C Mobley; Garry P Nolan; Steven T Rosen; Patrick Tan; Yun Yen; Ali Zarrinpar
Journal:  Trends Biotechnol       Date:  2020-01-21       Impact factor: 19.536

2.  Clinical testing should be individualized, not based on populations.

Authors:  David R Walt
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

3.  Proinflammatory and Anti-inflammatory Cytokine Response to Isometric Handgrip Exercise and the Effects of Duration and Intensity of the Isometric Efforts in Prehypertensive Participants.

Authors:  Udoji Godsday Ogbutor; Eze Kingsley Nwangwa; Bartholomew Chukwuebuka Nwogueze; John Chukwuka Igweh; Francis Chinedu Ugoeze; Emmanuel Ezunu; Ejime Agbonifo Chijiokwu
Journal:  J Chiropr Med       Date:  2022-07-20

4.  Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease.

Authors:  Becky C Carlyle; Robert R Kitchen; Zoe Mattingly; Amanda M Celia; Bianca A Trombetta; Sudeshna Das; Bradley T Hyman; Pia Kivisäkk; Steven E Arnold
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

5.  Increased Serum Levels of Proinflammatory Cytokines Are Accompanied by Fatigue in Military T-6A Texan II Instructor Pilots.

Authors:  Elizabeth G Damato; Seth J Fillioe; Seunghee P Margevicius; Ryan S Mayes; Jonathan E Somogyi; Ian S Vannix; Alireza Abdollahifar; Anthony M Turner; Lidia S Ilcus; Michael J Decker
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

6.  The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.

Authors:  Bianca A Trombetta; Becky C Carlyle; Aaron M Koenig; Leslie M Shaw; John Q Trojanowski; David A Wolk; Joseph J Locascio; Steven E Arnold
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

7.  Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults.

Authors:  Rym Ben-Othman; Bing Cai; Aaron C Liu; Natallia Varankovich; Daniel He; Travis M Blimkie; Amy H Lee; Erin E Gill; Mark Novotny; Brian Aevermann; Sibyl Drissler; Casey P Shannon; Sarah McCann; Kim Marty; Gordean Bjornson; Rachel D Edgar; David Tse Shen Lin; Nicole Gladish; Julia Maclsaac; Nelly Amenyogbe; Queenie Chan; Alba Llibre; Joyce Collin; Elise Landais; Khoa Le; Samantha M Reiss; Wayne C Koff; Colin Havenar-Daughton; Manraj Heran; Bippan Sangha; David Walt; Mel Krajden; Shane Crotty; Devin Sok; Bryan Briney; Dennis R Burton; Darragh Duffy; Leonard J Foster; William W Mohn; Michael S Kobor; Scott J Tebbutt; Ryan R Brinkman; Richard H Scheuermann; Robert E W Hancock; Tobias R Kollmann; Manish Sadarangani
Journal:  Front Immunol       Date:  2020-11-04       Impact factor: 7.561

8.  FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity.

Authors:  Koshu Okubo; Pei X Liew; Vijayashree Mysore; Xavier Cullere; Joseph Mears; Florencia Rosetti; Fan Zhang; Iris Madera-Salcedo; Frank Rosenbauer; Richard M Stone; Jon C Aster; Ulrich H von Andrian; Andrew H Lichtman; Soumya Raychaudhuri; Tanya N Mayadas
Journal:  Nat Commun       Date:  2021-08-09       Impact factor: 14.919

9.  Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC.

Authors:  Alissa Keegan; Biagio Ricciuti; Padric Garden; Limor Cohen; Reiko Nishihara; Anika Adeni; Cloud Paweletz; Julianna Supplee; Pasi A Jänne; Mariano Severgnini; Mark M Awad; David R Walt
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

10.  Circulating Interleukin-37 Levels in Healthy Adult Humans - Establishing a Reference Range.

Authors:  Danielle M Santarelli; Fabien B Vincent; Ina Rudloff; Claudia A Nold-Petry; Marcel F Nold; Marc A Russo
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.